Suppr超能文献

患者是否适合进行造血干细胞移植:患者相关变量的综述。

Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables.

机构信息

Alberta Blood and Marrow Transplant Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada.

出版信息

Bone Marrow Transplant. 2019 Mar;54(3):368-382. doi: 10.1038/s41409-018-0265-7. Epub 2018 Jul 9.

Abstract

Assessing patient eligibility for hematopoietic stem cell transplantation (HSCT) remains a complex, multifaceted challenge. Among these challenges, the paucity of comprehensive clinical data to guide decision making remains problematic coupled with unclear trade-offs between patient, disease and local HSCT center factors. Moreover, it is unclear that the modification of poor patient characteristics will improve post-HSCT outcomes. However, the use of Comorbidity Indices and Comprehensive Geriatric Assessments helps meet this challenge, but may be limited by overlapping patient characteristics. The increasing consideration for pre-HSCT psychosocial assessments and interventions remains to be studied. Ultimately, the decision to proceed with a HSCT remains interdisciplinary while considering the available evidence discussed in this review.

摘要

评估患者是否适合进行造血干细胞移植(HSCT)仍然是一个复杂的、多方面的挑战。在这些挑战中,缺乏全面的临床数据来指导决策仍然是一个问题,同时患者、疾病和当地 HSCT 中心因素之间的权衡也不明确。此外,改善患者特征是否会提高 HSCT 后的结果也不清楚。然而,使用合并症指数和全面老年评估有助于应对这一挑战,但可能受到重叠患者特征的限制。越来越多的人考虑在 HSCT 前进行心理社会评估和干预,但仍需要研究。最终,在考虑本综述中讨论的现有证据的同时,进行 HSCT 的决定仍然是跨学科的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验